Clinical Trial: A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07521241) titled 'A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults' on April 03.

Brief Summary: A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Chronic Liver Disease (CLD)

Intervention: DRUG: AD-230, AD-2301

Oral administration of AD-230 or AD-2301, according to randomized sequence.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Addpharma Inc.

Disclaimer: Curated by HT Syndication....